NCT04415372View on ClinicalTrials.gov

Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis

Enrolling by invitationOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

November 19, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Multiple SclerosisMS
Interventions
DIAGNOSTIC_TEST

MRI

The MRI protocol will include conventional testing for MS lesion detection and functional MR imaging to localize associated neurocognitive domains in each subject.

DIAGNOSTIC_TEST

Neuropsychological Testing

A comprehensive battery of neuropsychological tests will be administered to assess memory, new learning, spatial processing and higher executive function.

Trial Locations (1)

53705

University of Wisconsin, Madison, Madison

All Listed Sponsors
collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

lead

University of Wisconsin, Madison

OTHER